To create a machine that combines biotargeting with radiation and enable the first-ever systemic reach for radiotherapy for patients with any stage of cancer.
201 to 500 Employees
TypeCompany - Private
Revenue$1 to $5 million (USD)
IndustryBiotech & Pharmaceuticals
CompetitorsUnknown
Founded2009